← All trials
NCT01229917
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- —
- Primary completion
- —
- Completion date
- —
- First posted
- Oct 28, 2010
- Last posted
- Jul 7, 2011
- Enrollment
- —
- Arms / groups
- — / —
- Source
- AACT · ctgov ingestion
Sponsors
- Valio LtdLead sponsor
- University of HelsinkiCollaborator
- University of VirginiaCollaborator
- University of VirginiaOverall official - principal investigator
- Medcare LtdCollaborator
- University of VirginiaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.